GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MPH Health Care 93M1.DE · EUR

Health Care · XETRA · 🇩🇪 Germany

Compare

29.40

+2.44%

Close of 9 Nov 2026, in EUR

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in EUR, from our data supplier.

FY2025

Net income

€29.3m

FY2016FY2025

Free cash flow

€7.2m

FY2016FY2025

Shareholders' equity

€243.4m

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Research and development———€4€2€8€2———
Operating income€34.6m€33.0m€30.2m€29.6m−€8.7m−€70.6m€11.6m€43.7m€33.1m€7.9m
Net income€29.3m€32.0m€29.5m€29.1m−€9.0m−€70.4m€11.1m€37.0m€31.9m€80.1m
Diluted earnings per share6.847.486.906.80-2.09-16.432.568.627.6518.63

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assets€258.1m€291.1m€266.4m€237.0m€198.0m€210.7m€293.1m€286.3m€257.4m€230.3m
Cash and short-term investments€1.4m€1.2m€5.1m€3.8m€4.4m€4.2m€2.1m€1.1m€8.3m€10.4m
Total liabilities€14.7m€13.2m€15.4m€15.6m€5.7m€9.4m€21.5m€17.1m€16.7m€16.4m
Debt€11.6m€10.6m€13.1m€13.0m€4.1m€7.6m€18.6m€14.1m€14.1m€14.1m
Shareholders' equity€243.4m€277.9m€251.0m€221.4m€192.3m€201.3m€271.6m€269.1m€240.7m€213.9m
Shares outstanding4m4m4m4m4m4m4m4m4m4m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations€7.2m€1.8m−€2.0m€3,780−€1.3m−€3.4m−€1.4m€5.2m€1.0m−€4.8m
Capital spending−€7,861−€4,149−€4,698−€5,615−€2,270−€4,378−€52,466−€1,000−€2,000−€4,000
Free cash flow€7.2m€1.8m−€2.0m−€1,835−€1.3m−€3.4m−€1.4m€5.2m€1.0m−€4.8m
Dividends paid—−€5.1m————−€8.6m−€8.6m−€5.1m−€4.3m

Latest quarters

By quarter end

Jun 2026Dec 2025Jun 2025Dec 2024Jun 2024Dec 2023Jun 2023Dec 2022
Operating income€5.4m€107.6m−€73.0m−€42.8m€75.7m€45.8m−€15.6m€66.1m
Net income€5.0m€102.0m−€72.7m−€42.5m€74.5m€45.0m−€15.4m€65.1m
Diluted earnings per share1.1723.84-16.99-9.9217.4110.50-3.6015.21
Cash from operations€4.0m€6.0m—€2.0m——−€1.0m—
Capital spending−€4.0m−€6.0m—−€2.0m−€1.0m—−€1.0m—
Free cash flow€0€0—€0——−€2.0m—
Total assets€266.7m€258.1m€218.8m€291.1m€343.7m€266.4m€220.8m€237.0m
Cash and short-term investments€2.8m€1.4m€2.7m€1.2m€7.3m€5.1m€3.4m€3.8m
Debt€15.4m€11.6m€11.7m€10.5m€6.6m€13.1m€3.1m€13.0m
Shareholders' equity€248.4m€243.4m€205.1m€277.9m€325.5m€251.0m€206.0m€221.4m

Growth per year

Compound annual rate

3 years5 years10 years
Revenue276.1%—3.3%
Operating income5.4%—27.1%
Net income0.2%—-9.8%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin18.2%33.1%12.6%20.0%
Net margin16.6%31.2%10.7%38.5%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings3.23.02.42.3-10.2-1.415.44.34.82.0
Price to sales0.316.09.89.620.9-10.927.13.64.518.4

Dividends and splits

Per share, in the currency the company pays

Paid for 2 years. Last went ex-dividend on 18 Jul 2025.

FY2025FY2024FY2019FY2018FY2017FY2016FY2015
Paid in the year1.201.202.002.001.201.201.20
  • 10-to-1 reverse split · 22 Sept 2020
  • 1.04-for-1 split · 4 Sept 2014

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.